News
Barrington Research Maintains Outperform on SuRo Capital, Maintains $6 Price Target
14 Mar 24
News, Price Target, Analyst Ratings
Recap: SuRo Capital Q4 Earnings
13 Mar 24
Earnings
SuRo Capital Q4 2023 GAAP EPS $(0.11) Beats $(0.14) Estimate, Sales $2.460M Up From $1.463M YoY
13 Mar 24
Earnings, Earnings Beats, News
Earnings Scheduled For March 13, 2024
13 Mar 24
Earnings
Liquid Death Drinks In New Funding At $1.4B Valuation: Investor Anthony Pompliano Calls 'Putting Water In A Can' One Of His 'Best Investments'
12 Mar 24
News
Earnings Outlook For SuRo Capital
12 Mar 24
Earnings
SuRo Capital Corp. Will Commence A Modified Dutch Auction Tender Offer To Repurchase Up To 2M Shares Of Its Common Stock At A Price Per Share Not Less Than $4.00 And Not Greater Than $5.00 In $0.10 Increments, Using Available Cash.
14 Feb 24
M&A, News, Buybacks
SuRo Capital Corp. Q4 And Fiscal Year 2023 Preliminary Investment Portfolio Update; As Of December 31, 2023, SuRo Capital's Net Asset Value Is Estimated To Be Between $7.85-$8.35 Per Share
16 Jan 24
News, Guidance
Press releases
SuRo Capital Corp. Tender Offer Expiring on April 1, 2024 at 5:00 P.M., Eastern Time
22 Mar 24
Press Releases
Thinking about buying stock in Arena Group, Dunxin Financial Holdings, Nano-X Imaging, VBI Vaccines, or SuRo Capital?
15 Feb 24
Small Cap, Opinion, Press Releases
SuRo Capital Corp. Will Commence a Modified Dutch Auction Tender Offer to Repurchase up to 2 Million Shares of its Common Stock
14 Feb 24
Press Releases
SuRo Capital Corp. Fourth Quarter and Fiscal Year 2023 Preliminary Investment Portfolio Update
16 Jan 24
Press Releases